{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:42:06Z","timestamp":1792233726635,"version":"4.4.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hoc.2026.09.012","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:47:13Z","timestamp":1792230433000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet Dysfunction in Liver and Kidney Disease"],"prefix":"10.1016","author":[{"given":"Fynn L.","family":"Elvers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton","family":"Lisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2026.09.012_bib1","article-title":"Rebalanced hemostasis, bleeding and thrombosis in liver disease: a comprehensive review of pathophysiology, management and future perspectives","author":"Elvers","year":"2026","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.012_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212237","article-title":"Evaluation of hemostasis in patients with end-stage renal disease","volume":"14","author":"G\u00e4ckler","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cgh.2009.02.021","article-title":"Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis","volume":"7","author":"Qamar","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1681\/ASN.2020101440","article-title":"Platelet function in CKD: a systematic review and meta-analysis","volume":"32","author":"Baaten","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib5","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jtha.2025.08.025","article-title":"Major adverse thrombotic events and bleeding in stage 4 and 5 chronic kidney disease and dialysis-dependent end-stage kidney disease","volume":"23","author":"Wetmore","year":"2025","journal-title":"J Thromb Haemostasis"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1055\/a-1667-7293","article-title":"Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease","volume":"122","author":"Ow","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1055\/s-0043-1771187","article-title":"Platelet function decreases with increasing severity of liver cirrhosis and portal hypertension\u2014A prospective study","volume":"123","author":"Brusilovskaya","year":"2023","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib8","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12072-023-10577-y","article-title":"Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome","volume":"17","author":"Simbrunner","year":"2023","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemostasis"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0168-8278(02)00239-8","article-title":"Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease","volume":"37","author":"Pihusch","year":"2002","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.012_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.28853","article-title":"Low-grade endotoxemia and platelet activation in cirrhosis","volume":"65","author":"Raparelli","year":"2017","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.012_bib13","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2019-319044","article-title":"Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS","volume":"69","author":"Queck","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.hoc.2026.09.012_bib14","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2024.03.017","article-title":"Comprehensive investigation of platelet function in patients with cirrhosis","volume":"237","author":"Lecchi","year":"2024","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-016-1401-0","article-title":"Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation","volume":"43","author":"Egan","year":"2017","journal-title":"J Thromb Thrombolysis"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/liv.13167","article-title":"Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis","volume":"36","author":"Wu","year":"2016","journal-title":"Liver Int"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.012_bib17","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1538-7836.2006.02122.x","article-title":"No evidence for an intrinsic platelet defect in patients with liver cirrhosis - studies under flow conditions","volume":"4","author":"Lisman","year":"2006","journal-title":"J Thromb Haemostasis"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib18","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3390\/biomedicines11072057","article-title":"Decreased platelet aggregation in patients with decompensated liver cirrhosis and TIPS implantation","volume":"11","author":"Nassar","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib19","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jhep.2022.03.009","article-title":"Increased platelet aggregation in patients with decompensated cirrhosis indicates higher risk of further decompensation and death","volume":"77","author":"Zanetto","year":"2022","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.hoc.2026.09.012_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112583","article-title":"Effects of Increased Von Willebrand Factor Levels on Primary Hemostasis in Thrombocytopenic Patients with Liver Cirrhosis","volume":"9","author":"Wannhoff","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.012_bib21","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/jth.15653","article-title":"Evaluation of novel coagulation and platelet function assays in patients with chronic kidney disease","volume":"20","author":"Abdelmaguid","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2359643","article-title":"Decrease in platelet count in patients with AKI and its association with major adverse kidney events","volume":"46","author":"Medina-Gonz\u00e1lez","year":"2024","journal-title":"Ren Fail"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.012_bib23","article-title":"Impaired secondary platelet response in chronic kidney disease as a consequence of prior platelet activation","volume":"10","author":"Baaten","year":"2025","journal-title":"JACC, Basic Transl Sci"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib24","first-page":"614","article-title":"Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation","volume":"84","author":"Escolar","year":"1999","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib25","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/ijlh.13664","article-title":"Investigation of platelet function in patients with chronic kidney disease stages IV-V","volume":"43","author":"Khalid","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib26","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1182\/bloodadvances.2025017625","article-title":"Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming","volume":"10","author":"Carminita","year":"2026","journal-title":"Blood Adv"},{"issue":"21","key":"10.1016\/j.hoc.2026.09.012_bib27","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood.V118.21.5312.5312","article-title":"Von Willebrand Factor, ADAMTS13 Activity, TNF-Alpha, and Their Relationships in Patients with Chronic Kidney Disease","volume":"118","author":"Shen","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200537","article-title":"Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors","volume":"13","author":"Nieuwenhuijs-Moeke","year":"2018","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib29","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood.V75.7.1498.1498","article-title":"High von Willebrand factor concentration compensates a relative adhesion defect in uremic blood","volume":"75","author":"Zwaginga","year":"1990","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.012_bib30","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/jgh.14988","article-title":"Anemia and iron deficiency in compensated and decompensated cirrhosis: prevalence and impact on clinical outcomes","volume":"35","author":"Paternostro","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2369-12-53","article-title":"Baseline characteristics of patients with chronic kidney disease stage 3 and stage 4 in Spain: the MERENA observational cohort study","volume":"12","author":"Mart\u00ednez-Castelao","year":"2011","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.hoc.2026.09.012_bib32","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2003.10.037","article-title":"Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study","volume":"43","author":"Landray","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib33","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1378\/chest.124.3.1016","article-title":"Cirrhosis as a risk factor for sepsis and death","volume":"124","author":"Foreman","year":"2003","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1160\/TH04-08-0467","article-title":"Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation","volume":"93","author":"Reiter","year":"2005","journal-title":"Thromb Haemost"},{"issue":"8567","key":"10.1016\/j.hoc.2026.09.012_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.012_bib36","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/apt.14600","article-title":"Platelet-leucocyte aggregation is augmented in cirrhosis and further increased by platelet transfusion","volume":"47","author":"St\u00f8y","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"issue":"09","key":"10.1016\/j.hoc.2026.09.012_bib37","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1055\/s-0037-1616140","article-title":"Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis","volume":"86","author":"Sirolli","year":"2001","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.gastro.2023.05.046","article-title":"Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective, multicenter observational study","volume":"165","author":"Intagliata","year":"2023","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.hoc.2026.09.012_bib39","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1681\/ASN.2015050535","article-title":"The risk of major hemorrhage with CKD","volume":"27","author":"Molnar","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib40","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/jth.15508","article-title":"Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: from the VIVALDI, a population-based prospective cohort study","volume":"19","author":"K\u00f6nigsbr\u00fcgge","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib41","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/jth.15888","article-title":"Predicting bleeding after liver biopsy using comprehensive clinical and laboratory investigations: a prospective analysis of 302 procedures","volume":"20","author":"Bissonnette","year":"2022","journal-title":"J Thromb Haemostasis"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ajg.2017.457","article-title":"Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study","volume":"113","author":"Basili","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102520","article-title":"Spontaneous bleeding in chronic kidney disease: global coagulation assays may predict bleeding risk","volume":"8","author":"Brook","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib44","article-title":"Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD","volume":"6","author":"Balcar","year":"2024","journal-title":"JHEP Rep"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib45","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/HEP.0000000000000740","article-title":"Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis","volume":"80","author":"Hofer","year":"2024","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.thromres.2008.07.001","article-title":"Use of the platelet function analyzer to minimize bleeding complications after renal biopsy","volume":"123","author":"van den Hoogen","year":"2009","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/tri.13090","article-title":"Routine haemostasis testing before transplanted kidney biopsy: a cohort study","volume":"31","author":"Kuiper","year":"2018","journal-title":"Transpl Int"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2026.2614709","article-title":"Prediction of bleeding and thromboembolic complications in patients on chronic hemodialysis with the total thrombus-formation analysis system","volume":"37","author":"Dimitrijevic","year":"2026","journal-title":"Platelets"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib49","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","author":"Villa","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.hoc.2026.09.012_bib51","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/nep.13662","article-title":"KHA-CARI guideline recommendations for renal biopsy","volume":"24","author":"MacGinley","year":"2019","journal-title":"Nephrology"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib52","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s11239-026-03249-9","article-title":"Efficacy and safety of perioperative thrombopoietin receptor agonists in patients with immune thrombocytopenia and thrombocytopenia secondary to chronic liver disease undergoing elective procedures: a systematic review and meta-analysis","volume":"59","author":"Shakir","year":"2026","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.joms.2009.07.081","article-title":"Intranasal desmopressin versus blood transfusion in cirrhotic patients with coagulopathy undergoing dental extraction: a randomized controlled trial","volume":"68","author":"Stanca","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib54","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/liv.12765","article-title":"Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis","volume":"35","author":"Arshad","year":"2015","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib55","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jth.15364","article-title":"Treatment of bleeding in patients with liver disease","volume":"19","author":"Northup","year":"2021","journal-title":"J Thromb Haemostasis"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib56","article-title":"Effect of desmopressin on bleeding outcomes after native renal biopsy: a systematic review and meta-analysis","volume":"15","author":"Ali","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfag083","article-title":"Bleeding prevention with desmopressin for allograft kidney biopsies: a double-blind randomized study","volume":"19","author":"Pacini","year":"2026","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib58","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib59","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/hep.32019","article-title":"Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nation-wide cohort study","volume":"74","author":"Jepsen","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1053\/j.ajkd.2025.08.011","article-title":"Trends in major cardiovascular events and bleeding among patients with advanced CKD: a nationwide Swedish study","volume":"87","author":"Faucon","year":"2026","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib61","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/liv.15435","article-title":"Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosis","volume":"43","author":"Zanetto","year":"2023","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0427","article-title":"Representation of patients with chronic kidney disease in clinical trials of cardiovascular disease medications: a systematic review","volume":"7","author":"Colombijn","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hoc.2026.09.012_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100222","article-title":"Antithrombotic therapy in patients with liver disease: population-based insights on variations in prescribing trends, adherence, persistence and impact on stroke and bleeding","volume":"10","author":"Chang","year":"2021","journal-title":"The Lancet Regional Health - Europe"},{"issue":"3","key":"10.1016\/j.hoc.2026.09.012_bib64","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCULATIONAHA.109.865352","article-title":"Use of evidence-based therapies in short-term outcomes of ST-Segment elevation myocardial infarction and Non\u2013ST-Segment elevation myocardial infarction in patients with chronic kidney disease","volume":"121","author":"Fox","year":"2010","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.012_bib65","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012236","article-title":"Safety of dual-antiplatelet therapy after myocardial infarction among patients with chronic kidney disease","volume":"8","author":"Rymer","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.012_bib66","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/ndt\/gft103","article-title":"Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy","volume":"28","author":"Gremmel","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib67","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jcin.2019.08.038","article-title":"Clopidogrel responsiveness in patients with decompensated cirrhosis of the liver undergoing pre-transplant PCI","volume":"13","author":"Trankle","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.001683","article-title":"Prevalence and impact of high platelet reactivity in chronic kidney disease","volume":"8","author":"Baber","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib69","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.hoc.2026.09.012_bib70","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1016\/j.jtha.2026.03.018","article-title":"Visualization of intrahepatic activation of coagulation and its contribution to disease progression in mice with acetaminophen-induced acute liver injury","volume":"24","author":"von Meijenfeldt","year":"2026","journal-title":"J Thromb Haemostasis"},{"issue":"8","key":"10.1016\/j.hoc.2026.09.012_bib71","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/gut.2010.235689","article-title":"Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension","volume":"60","author":"La Mura","year":"2011","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.hoc.2026.09.012_bib72","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/hep.31507","article-title":"VWF\/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure","volume":"73","author":"Driever","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation driven platelet activation reduces cholestatic liver injury and fibrosis in mice","volume":"13","author":"Joshi","year":"2015","journal-title":"J Thromb Haemostasis"},{"issue":"4","key":"10.1016\/j.hoc.2026.09.012_bib74","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.hoc.2026.09.012_bib75","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1001\/jama.2024.1215","article-title":"Aspirin for metabolic dysfunction\u2013associated steatotic liver disease without cirrhosis","volume":"331","author":"Simon","year":"2024","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.hoc.2026.09.012_bib76","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1096\/fj.202000897R","article-title":"Platelet inhibition by ticagrelor is protective against diabetic nephropathy in mice","volume":"34","author":"Uil","year":"2020","journal-title":"FASEB J"},{"issue":"1","key":"10.1016\/j.hoc.2026.09.012_bib77","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s10020-025-01355-7","article-title":"Platelets induce epithelial to mesenchymal transition in renal proximal tubular epithelial cells through TGF-\u03b2 signaling pathway","volume":"31","author":"Rustiasari","year":"2025","journal-title":"Molecular Medicine"},{"issue":"6","key":"10.1016\/j.hoc.2026.09.012_bib78","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2022.02.019","article-title":"Effect of aspirin on CKD progression in older adults: secondary analysis from the ASPREE randomized clinical trial","volume":"80","author":"Polkinghorne","year":"2022","journal-title":"Am J Kidney Dis"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882600122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985882600122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:47:24Z","timestamp":1792230444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985882600122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":78,"alternative-id":["S088985882600122X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2026.09.012","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet Dysfunction in Liver and Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2026.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}